Across TCGA patient cohorts, CDY20P RNA expression is significantly associated with the mutation status of many other genes, with 7 significant associations in total. PRAD shows the largest number of these associations.

The most reproducible CDY20P-associated genes across cancer lineages are PHF24, SLC5A12, and PCDH19. Each is linked with CDY20P in more than 1 cancer types. Because this analysis shows association rather than direction, both CDY20P-to-partner and partner-to-CDY20P results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CDY20P→partner) and Y-score (partner→CDY20P) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
PRAD	PHF24 →	+7.939	+0.034	.008	<.001	3	1
PRAD	SLC5A12 →	+7.939	+0.034	.008	<.001	3	1
PRAD	PCDH19 →	+7.939	+0.024	.008	<.001	3	1
PRAD	CTC1 →	+7.939	+0.034	.008	<.001	3	1
PRAD	SOCS4 →	+7.939	+0.024	.008	<.001	3	1
PRAD	EPHA3 →	+7.939	+0.024	.008	<.001	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 7 associations by consensus.

Exploration

CDY20P survival (RNA) · tumor vs normal (RNA) · all CDY20P data types